The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBank Of Georgia Group Regulatory News (BGEO)

Share Price Information for Bank Of Georgia Group (BGEO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5,360.00
Bid: 5,340.00
Ask: 5,360.00
Change: 70.00 (1.32%)
Spread: 20.00 (0.375%)
Open: 5,320.00
High: 5,390.00
Low: 5,250.00
Prev. Close: 5,290.00
BGEO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

28 Sep 2017 09:13

RNS Number : 0814S
Bgeo Group PLC
28 September 2017
 

London, 28 September 2017

 

BGEO Group announces market purchase of shares for its Employee Benefit Trust

BGEO Group PLC (BGEO or the Group) was notified by Sanne Fiduciary Services Limited (Sanne), acting as trustee of the Rubicon Executive Equity Compensation Trust (Trust), that Sanne, through an independent broker-managed buyback programme, purchased in the market 30,086 BGEO ordinary shares (Shares) at a price of £32.35 (rounded to two decimal points) per Share, traded on 27 September 2017 with a settlement date of 29 September 2017. 

The Trust holds the Shares for the purpose of satisfying awards to be awarded to beneficiaries of the Trust. The executive directors and persons discharging managerial responsibility of the Group are potential beneficiaries under the Trust and are therefore treated as having an interest in such Shares.

Upon settlement of the above transaction, the Trust will hold a total of 1,536,730 Shares, representing approximately 3.90% of BGEO's issued ordinary share capital.

Of the 1,536,730 Shares held by the Trust, 1,367,394 Shares are to be allocated to existing awards, both vested and unvested.

 

Name of authorised official of issuer responsible for making notification: Rebecca Wooldridge, Company Secretary

 

About BGEO Group PLC

The Group: BGEO Group PLC ("BGEO"- LSE: BGEO LN) is a UK incorporated holding company of a Georgia-focused investment platform. BGEO invests, via its subsidiaries, in the banking and non-banking sectors in Georgia (BGEO and its subsidiaries, together the "Group"). BGEO aims to deliver on a 4x20 strategy: (1) at least 20% ROAE from its Banking Business; (2) at least 20% growth of its Banking Business retail loan book; (3) at least 20% IRR; and (4) up to 20% of the Group's profit from its Investment Business. On 3 July 2017 BGEO announced its intention to demerge BGEO Group PLC into a London-listed banking business (the "Banking Business") and a London-listed investment business (the "Investment Business") by the end of the first half of 2018. 

Banking Business: Currently representing at least 80% of the Group's profit, will comprise: a) retail banking and payment services, b) corporate investment banking and wealth management operations and c) banking operations in Belarus ("BNB"). JSC Bank of Georgia ("BOG" or the "Bank") is the core entity of the Group's Banking Business. The Banking Business will continue to target to benefit from the underpenetrated banking sector in Georgia primarily through its retail banking services.

Investment Business: Currently representing up to 20% of the Group's profit, will comprise the Group's stakes in Georgia Healthcare Group PLC ("Healthcare Business" or "GHG") - an LSE (London Stock Exchange PLC) premium-listed company, Georgia Global Utilities ("Utility and Energy Business" or "GGU"), m2 Real Estate ("Real Estate Business" or "m2"), Teliani Valley ("Beverage Business" or "Teliani") and Aldagi ("Property and Casualty Insurance Business" or Aldagi"). Georgia's fast-growing economy provides opportunities in a number of underdeveloped local markets and the Investment Business will target to capture growth opportunities in the Georgian corporate sector.

 

JSC BGEO Group has, as of the date hereof, the following credit ratings:

Bank of Georgia has, as of the date hereof, the following credit ratings:

Fitch Ratings

'BB-/B'

Fitch Ratings

'BB-/B'

Moody's

B1/NP (FC) & B1/NP (LC)

Moody's

'Ba3/NP' (FC) & 'Ba2/NP' (LC)

 

For further information, please visit www.bgeo.com or contact: 

Irakli Gilauri

Michael Oliver

Giorgi Alpaidze

Group CEO

Adviser to the CEO

Group CFO

+995 322 444 109

+44 203 178 4034

+995 322 444 190

igilauri@bgeo.com

moliver@bgeo.com

g.alpaidze@bgeo.com

 

 

This news report is presented for general informational purposes only and should not be construed as an offer to sell or the solicitation of an offer to buy any securities

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHGIGDCGBDBGRI
Date   Source Headline
15th Mar 20236:09 pmRNSTransaction in Own Shares
14th Mar 20235:23 pmRNSTransaction in Own Shares
13th Mar 20235:30 pmRNSTransaction in Own Shares
10th Mar 20235:20 pmRNSTransaction in Own Shares
9th Mar 20235:10 pmRNSTransaction in Own Shares
8th Mar 20235:11 pmRNSTransaction in Own Shares
7th Mar 20235:23 pmRNSTransaction in Own Shares
6th Mar 20235:52 pmRNSTransaction in Own Shares
3rd Mar 20235:46 pmRNSTransaction in Own Shares
2nd Mar 20235:16 pmRNSTransaction in Own Shares
1st Mar 20235:14 pmRNSTransaction in Own Shares
1st Mar 202312:21 pmRNSTotal Voting Rights
28th Feb 20235:19 pmRNSTransaction in Own Shares
27th Feb 20235:47 pmRNSTransaction in Own Shares
27th Feb 202312:15 pmRNSDirector/PDMR Shareholding
24th Feb 20233:07 pmRNSDirector/PDMR Shareholding
16th Feb 20237:05 amRNSBOGG PLC announces extension of share buybacks
16th Feb 20237:00 amRNSBOGG PLC 4Q22 & FY22 preliminary financial results
10th Feb 20233:00 pmRNSBOGG PLC Notice of 4Q22 and FY22 Results
5th Jan 20234:30 pmRNSDirector/PDMR Shareholding
3rd Jan 202311:22 amRNSTotal Voting Rights
30th Dec 202212:30 pmRNSBOGG PLC announces settlement of legacy claim
28th Dec 20221:00 pmRNSBOGG announces amendment to taxation model
19th Dec 202211:00 amRNSBOGG announces promotions within management team
16th Dec 20223:29 pmRNSCancellation of Treasury Shares
16th Dec 20222:17 pmRNSDirectorate Change
12th Dec 20224:53 pmRNSTransaction in Own Shares
9th Dec 20225:03 pmRNSTransaction in Own Shares
9th Dec 20223:15 pmRNSDirector/PDMR Shareholding
8th Dec 20225:17 pmRNSTransaction in Own Shares
7th Dec 20225:27 pmRNSTransaction in Own Shares
6th Dec 20225:17 pmRNSTransaction in Own Shares
6th Dec 20222:54 pmRNSDirector/PDMR Shareholding - Replacement
6th Dec 202212:13 pmRNSDirector/PDMR Shareholding
5th Dec 20224:59 pmRNSTransaction in Own Shares
5th Dec 20222:45 pmRNSDirector/PDMR Shareholding
2nd Dec 20225:21 pmRNSTransaction in Own Shares
2nd Dec 20222:25 pmRNSDirector/PDMR Shareholding
1st Dec 20225:11 pmRNSTransaction in Own Shares
1st Dec 202211:46 amRNSTotal Voting Rights
30th Nov 20225:06 pmRNSTransaction in Own Shares
30th Nov 20223:48 pmRNSDirector/PDMR Shareholding
30th Nov 20223:27 pmRNSCancellation of Treasury Shares
29th Nov 20225:11 pmRNSTransaction in Own Shares
28th Nov 20225:41 pmRNSDirector/PDMR Shareholding
28th Nov 20225:03 pmRNSTransaction in Own Shares
25th Nov 20225:00 pmRNSTransaction in Own Shares
25th Nov 20223:58 pmRNSDirector/PDMR Shareholding
25th Nov 20229:17 amRNSCompany Secretary Change
24th Nov 20225:28 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.